Previous close | 53.50 |
Open | 53.39 |
Bid | 53.04 x 400 |
Ask | 53.08 x 400 |
Day's range | 52.81 - 53.67 |
52-week range | 50.27 - 67.36 |
Volume | |
Avg. volume | 1,896,804 |
Market cap | 11.914B |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | 16.08 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WILMINGTON, Del., May 02, 2024--Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 at 8:00 a.m. (PDT) in Las Vegas.
WILMINGTON, Del., April 30, 2024--Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
WILMINGTON, Del. & SAN DIEGO, April 23, 2024--Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists